PRICE T ROWE ASSOCIATES INC /MD/ - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 371 filers reported holding GLOBUS MED INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$53,616
-9.0%
1,079,855
+9.1%
0.01%0.0%
Q2 2023$58,920
+19.3%
989,560
+13.5%
0.01%
+14.3%
Q1 2023$49,397
-23.9%
872,109
-0.2%
0.01%
-30.0%
Q4 2022$64,905
-99.9%
873,901
+0.2%
0.01%
+11.1%
Q3 2022$51,931,000
+6.8%
871,758
+0.6%
0.01%
+50.0%
Q2 2022$48,645,000
-23.4%
866,491
+0.6%
0.01%0.0%
Q1 2022$63,544,000
+2.7%
861,267
+0.5%
0.01%0.0%
Q4 2021$61,893,000
-7.5%
857,238
-1.8%
0.01%0.0%
Q3 2021$66,889,000
-1.6%
872,993
-0.5%
0.01%0.0%
Q2 2021$67,992,000
+27.7%
876,981
+1.6%
0.01%
+20.0%
Q1 2021$53,241,000
-7.2%
863,318
-1.8%
0.01%
-16.7%
Q4 2020$57,343,000
+33.7%
879,225
+1.5%
0.01%
+20.0%
Q3 2020$42,890,000
+4.3%
866,110
+0.5%
0.01%0.0%
Q2 2020$41,114,000
+10.8%
861,746
-1.2%
0.01%
-16.7%
Q1 2020$37,113,000
-27.7%
872,630
+0.0%
0.01%
-14.3%
Q4 2019$51,361,000
+20.5%
872,293
+4.6%
0.01%
+16.7%
Q3 2019$42,617,000
+28.0%
833,659
+5.9%
0.01%
+20.0%
Q2 2019$33,290,000
-14.4%
787,000
-0.0%
0.01%
-16.7%
Q1 2019$38,905,000
+17.5%
787,388
+2.9%
0.01%0.0%
Q4 2018$33,103,000
-18.4%
764,854
+7.0%
0.01%0.0%
Q3 2018$40,567,000
+67.0%
714,716
+48.5%
0.01%
+50.0%
Q2 2018$24,287,000
+2503.1%
481,314
+2471.4%
0.00%
Q1 2018$933,000
+22.1%
18,718
+0.7%
0.00%
Q4 2017$764,000
+38.2%
18,583
-0.1%
0.00%
Q3 2017$553,000
-10.4%
18,6030.0%0.00%
Q2 2017$617,000
+12.0%
18,603
+0.1%
0.00%
Q1 2017$551,000
+67.5%
18,593
+40.0%
0.00%
Q4 2016$329,000
+9.7%
13,2800.0%0.00%
Q3 2016$300,000
-5.1%
13,2800.0%0.00%
Q2 2016$316,000
+0.3%
13,2800.0%0.00%
Q1 2016$315,000
-14.6%
13,2800.0%0.00%
Q4 2015$369,000
+74.9%
13,280
+30.2%
0.00%
Q3 2015$211,000
-19.5%
10,2000.0%0.00%
Q2 2015$262,000
+1.9%
10,2000.0%0.00%
Q1 2015$257,000
+6.2%
10,2000.0%0.00%
Q4 2014$242,000
+20.4%
10,2000.0%0.00%
Q3 2014$201,000
-79.0%
10,200
-74.5%
0.00%
Q2 2014$958,000
-79.6%
40,061
-77.3%
0.00%
-100.0%
Q1 2014$4,694,000
-78.5%
176,549
-83.6%
0.00%
-50.0%
Q4 2013$21,788,000
-10.8%
1,079,638
-22.8%
0.00%
-66.7%
Q3 2013$24,421,0001,398,6850.01%
Other shareholders
GLOBUS MED INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 373,254$26,949,00017.58%
Next Capital Management LLC 111,098$8,021,0005.42%
Sterling Investment Advisors, Ltd. 188,123$13,582,0003.82%
Integral Health Asset Management, LLC 180,000$12,996,0003.60%
Pembroke Management, LTD 602,447$43,497,0003.19%
Godshalk Welsh Capital Management, Inc. 73,435$5,302,0003.02%
XXEC, Inc. 51,925$3,420,0002.92%
Sivik Global Healthcare LLC 75,000$5,415,0002.32%
PARADIGM CAPITAL MANAGEMENT INC/NY 654,100$47,226,0002.11%
Van Berkom & Associates Inc. 929,856$67,136,0001.98%
View complete list of GLOBUS MED INC shareholders